The anti-leukemic activity of sodium dichloroacetate in p53mutated/null cells is mediated by a p53-independent ILF3/p21 pathway
about
The presence of wild type p53 in hematological cancers improves the efficacy of combinational therapy targeting metabolismMetformin combined with sodium dichloroacetate promotes B leukemic cell death by suppressing anti-apoptotic protein Mcl-1.Novel role of prostate apoptosis response-4 tumor suppressor in B-cell chronic lymphocytic leukemia.
P2860
The anti-leukemic activity of sodium dichloroacetate in p53mutated/null cells is mediated by a p53-independent ILF3/p21 pathway
description
2015 nî lūn-bûn
@nan
2015 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
The anti-leukemic activity of ...... 3-independent ILF3/p21 pathway
@ast
The anti-leukemic activity of ...... 3-independent ILF3/p21 pathway
@en
type
label
The anti-leukemic activity of ...... 3-independent ILF3/p21 pathway
@ast
The anti-leukemic activity of ...... 3-independent ILF3/p21 pathway
@en
prefLabel
The anti-leukemic activity of ...... 3-independent ILF3/p21 pathway
@ast
The anti-leukemic activity of ...... 3-independent ILF3/p21 pathway
@en
P2093
P2860
P356
P1433
P1476
The anti-leukemic activity of ...... 3-independent ILF3/p21 pathway
@en
P2093
Antonio Cuneo
Chiara Agnoletto
Elisabetta Melloni
Erika Rimondi
Gian Matteo Rigolin
Giorgio Zauli
Laura Brunelli
Paola Secchiero
Roberta Pastorelli
P2860
P304
P356
10.18632/ONCOTARGET.2960
P407
P577
2015-02-01T00:00:00Z